Haloperidol Metabolite II Valproate Ester (
Angiogenesis Inhibitors
/ chemical synthesis
Butyrophenones
/ chemical synthesis
Cell Line, Tumor
Cell Proliferation
/ drug effects
Cell Survival
/ drug effects
Humans
Melanoma
/ drug therapy
Pentanoic Acids
/ chemical synthesis
Piperidines
/ cerebrospinal fluid
Prodrugs
/ chemical synthesis
Stereoisomerism
Uveal Neoplasms
/ drug therapy
Valerates
/ cerebrospinal fluid
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
23 09 2021
23 09 2021
Historique:
pubmed:
4
9
2021
medline:
15
12
2021
entrez:
3
9
2021
Statut:
ppublish
Résumé
Increased angiogenesis and vascular endothelial growth factor (VEGF) levels contribute to higher metastasis and mortality in uveal melanoma (UM), an aggressive malignancy of the eye in adults.
Identifiants
pubmed: 34477381
doi: 10.1021/acs.jmedchem.1c00995
pmc: PMC8474110
doi:
Substances chimiques
Angiogenesis Inhibitors
0
Butyrophenones
0
MRJF22
0
Pentanoic Acids
0
Piperidines
0
Prodrugs
0
Valerates
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13622-13632Références
Adv Exp Med Biol. 2017;964:1-4
pubmed: 28315260
Life Sci. 1995;57(4):PL57-62
pubmed: 7603301
Eur J Med Chem. 2015 Jan 27;90:1-9
pubmed: 25461306
J Hematol Oncol. 2010 Feb 04;3:5
pubmed: 20132536
Eur J Pharmacol. 1995 Jul 14;280(3):301-10
pubmed: 8566098
Anticancer Res. 2015 Jun;35(6):3129-35
pubmed: 26026072
Clin Exp Metastasis. 2002;19(3):233-46
pubmed: 12067204
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9
pubmed: 14578381
J Med Chem. 1970 Mar;13(2):302-3
pubmed: 5418508
PLoS One. 2012;7(3):e33453
pubmed: 22479401
Int J Oncol. 2016 Nov;49(5):1773-1784
pubmed: 27826619
Molecules. 2020 Nov 20;25(22):
pubmed: 33233619
Eur J Med Chem. 2011 Jan;46(1):433-8
pubmed: 21055848
Bioorg Med Chem Lett. 2002 Feb 11;12(3):497-500
pubmed: 11814827
Clin Cancer Res. 2012 Jan 15;18(2):408-16
pubmed: 22038994
Clin Cancer Res. 2012 Jul 1;18(13):3509-15
pubmed: 22535155
Clin Cancer Res. 2011 Oct 15;17(20):6574-81
pubmed: 21880788
J Surg Res. 2009 May 15;153(2):347-58
pubmed: 19027922
In Vivo. 2013 Nov-Dec;27(6):685-94
pubmed: 24292569
DNA Cell Biol. 2020 Feb;39(2):167-176
pubmed: 31808715
J Pharm Sci. 2006 Jun;95(6):1177-95
pubmed: 16639719
Ophthalmology. 2015 Mar;122(3):538-44
pubmed: 25315663
ACS Med Chem Lett. 2020 Oct 27;11(12):2406-2413
pubmed: 33329762
Mol Cancer. 2006 Dec 11;5:71
pubmed: 17156483
Eur J Med Chem. 2021 Jan 1;209:112906
pubmed: 33049607
Am J Ophthalmol. 2013 Mar;155(3):429-437.e7
pubmed: 23218699
J Med Chem. 2016 Nov 10;59(21):9960-9966
pubmed: 27739690
Pharmacol Rev. 1990 Dec;42(4):355-402
pubmed: 1964225
J Natl Cancer Inst. 1999 Feb 17;91(4):359-67
pubmed: 10050870
Eye (Lond). 2017 Feb;31(2):241-257
pubmed: 27911450
Arch Ophthalmol. 2006 Oct;124(10):1428-34
pubmed: 17030710
Cancer. 2016 Aug 1;122(15):2299-312
pubmed: 26991400
Psychopharmacology (Berl). 1994 May;114(4):559-65
pubmed: 7855217
Oncotarget. 2017 Jul 25;8(53):91099-91111
pubmed: 29207628
Arch Ophthalmol. 2008 Oct;126(10):1413-8
pubmed: 18852420
Cancer Res. 2016 Feb 1;76(3):607-18
pubmed: 26645564
Br J Ophthalmol. 2015 Nov;99(11):1550-3
pubmed: 25904122
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5576-82
pubmed: 17122151
Ocul Oncol Pathol. 2019 Apr;5(3):153-161
pubmed: 31049320
Int J Mol Sci. 2020 Aug 03;21(15):
pubmed: 32756477
Clin Cancer Res. 2007 Apr 15;13(8):2318-22
pubmed: 17438089
Int J Biol Sci. 2014 Jul 02;10(7):757-70
pubmed: 25013383
Ecancermedicalscience. 2013 Jul 31;7:336
pubmed: 23914254
Cancer Med. 2013 Oct;2(5):674-86
pubmed: 24403233
Pharm Res. 1991 Aug;8(8):1002-5
pubmed: 1924152
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7160-7165
pubmed: 28559337
Pharm Acta Helv. 2000 Mar;74(2-3):211-8
pubmed: 10812960